Citations

Clear

7552 citation(s) found for "Ku, Matthew".

Postnatal survival of phrenic motor neurons is promoted by BDNF/TrkB.FL signaling
Brandenburg, Joline E. , Fogarty, Matthew J. , Zhan, Wen‐Zhi, Kopper, Leo A., Sieck, Gary C. , Sieck, Gary , Fogarty, Matthew J

Mayo Clinic

Journal of Applied Physiology | March 21, 2024 | Volume: 136 | Issue: 5 | Pages: 1113-1121

10.1152/japplphysiol.00911.2023 | PMID 38511211 Get It

During early postnatal development, BDNF/TrkB signaling promotes PhMN survival. Inhibition of BDNF/TrkB signaling in early postnatal development does not impact PhMN size. Inhibition of BDNF/TrkB signaling in early postnatal development does not impact the number or CSA of DIAm fibers.
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B‐cell lymphoma after 2 or more lines of prior therapy
Lunning, Matthew A. , Wang, Hailin , Hu, Zhen‐Huan , Jacobson, Caron A. , Miklos, David B. , Hill, Brian T. , Neelapu, Sattva S. , Dieyi, C., Field, Polly, Miao, Harry , Shahani, Shilpa, Patel, Anik R. , Spooner, Clare, Fu, Christine, Muramoto, David, Xu, Hairong, Pasquini, Marcelo C. , Westin, Jason R , Miklos, David B , Locke, Frederick L. , Siddiqi, Tanya , Ahmed, Sairah , Lin, Yi , Ghobadi, Armin , Westin, Jason R.

Mayo Clinic

American Journal of Hematology | March 20, 2024 | Volume: 99 | Issue: 5 | Pages: 880-889

10.1002/ajh.27283 | PMID 38504387 Get It

AbstractAxicabtagene ciloleucel (axi‐cel) in trials has demonstrated favorable efficacy compared with historical controls after ≥2 lines of therapy for the treatment of relapsed or refractory (R/R) large B cell lymphoma (LBCL). Herein, we compared the real‐world effectiveness of axi‐cel with efficacy and effectiveness of chemoimmunotherapy (CIT) in patients aged ≥65 years and patients with Eastern Cooperative Oncology Group performance status (ECOG PS) of 2. A total of 1146 patients treated with commercial axi‐cel for R/R LBCL with ≥2 lines of prior therapy were included from the Center for International Blood and Marrow Transplantation Research prospective observational study, and 469 patients treated with CIT for R/R LBCL after ≥2 lines of prior therapy were included from SCHOLAR‐1 (an international, multicohort, retrospective study). After propensity score matching, at a median follow‐up of 24 months for patients receiving axi‐cel and 60 months for patients receiving CIT, 12‐month overall survival rates were 62% and 28%, respectively (hazard ratio, 0.30 [95% CI, 0.24–0.37]). Objective response rate (ORR) was 76% (complete response [CR] rate 58%) in patients receiving axi‐cel versus 28% (CR rate 16%) for those receiving CIT. A 57% difference in ORR (55% difference in CR rate) favoring axi‐cel over CIT was observed among patients aged ≥65 years. Increased magnitude of benefit in response rates for axi‐cel versus CIT was also observed among patients with ECOG PS = 2. These findings further support the broader use of axi‐cel in older patients and patients with ECOG PS = 2 with R/R LBCL.
Immunoprofiles and Oncologic Outcomes of 15 Patients with Androgen Receptor-Positive Salivary Duct Carcinoma
Gogineni, Emile , Sells, Blake , Dibs, Khaled , Jhawar, Sachin R. , Limbach, Abberly Lott , Konieczkowski, David J. , Jun, Sung , Baliga, Sujith , Mitchell, Darrion , Grecula, J.C., Bonomi, Marcelo , Bhateja, Priyanka, Old, Matthew , Seim, Nolan B. , Kang, Stephen Y. , Rocco, James W. , Chakravarti, Arnab , Blakaj, Dukagjin , Gamez, Mauricio E. , Sells, Blake E , Ma, Sung J , Mitchell, Darrion L , Bonomi, Marcelo , Bhateja, Priyanka , Jhawar, Sachin R , Chakravarti, Arnab , Haring, Catherine T. , Zhu, Simeng

Mayo Clinic

Cancers | March 19, 2024 | Volume: 16 | Issue: 6 | Pages: 1204

10.3390/cancers16061204 | PMID 38539538 Get It

Background: Salivary duct carcinomas (SDC) are a rare and aggressive subtype of salivary gland neoplasm. They can present with distinct immunoprofiles, such as androgen receptor (AR) and HER-2/Neu-positivity. To date, no consensus exists on how to best manage this entity. Methods: All patients diagnosed with nonmetastatic AR+ SDC of the parotid from 2013 to 2019 treated with curative intent were included. Immunologic tumor profiling was conducted using 24 distinct markers. Kaplan–Meier analyses were used to estimate locoregional recurrence (LRR), distant control, and overall survival (OS). Results: Fifteen patients were included. Nine (60%) patients presented with T4 disease and eight (53%) had positive ipsilateral cervical lymphadenopathy. Ten (67%) patients underwent trimodality therapy, including surgery followed by adjuvant radiation and concurrent systemic therapy. The median follow-up was 5.5 years (interquartile range, 4.8–6.1). The estimated 5-year rates of LRR, distant progression, and OS were 6%, 13%, and 87%, respectively. Conclusion: Despite only including AR+ SDC of the parotid, immunoprofiles, such as expression of HER-2, were highly variable, highlighting the potential to tailor systemic regimens based on individual histologic profiles in the future. Studies with larger patient numbers using tumor-specific molecular profiling and tumor heterogeneity analyses are justified to better understand the biology of these tumors. Molecularly informed treatment approaches, including the potential use of AR- and HER-2/Neu-directed therapies upfront in the definitive setting, may hold future promise to further improve outcomes for these patients.
Evaluation of Sonicate Fluid Culture Cutoff Points for Periprosthetic Joint Infection Diagnosis
Otero, Judith Álvarez , Karau, Melissa J. , Greenwood‐Quaintance, Kerryl E. , Mandrekar, Jay , Patel, Robin , Alvarez Otero, Judith, Patel, Robin , Abdel, Matthew P.

Mayo Clinic

Open Forum Infectious Diseases | March 19, 2024 | Volume: 11 | Issue: 5 | Pages: No page available

10.1093/ofid/ofae159 | PMID 38715572 Get It

Abstract Introduction Implant sonication is useful for recovery of periprosthetic joint infection (PJI) pathogens in culture, but exact cutoff points for definition of clinically significant sonicate fluid culture results vary from study to study. The aim of this study was to define ideal sonicate fluid culture cutoff points for PJI diagnosis. Methods Sonicate fluid cultures from hip and knee prosthesis components removed between February 2007 and December 2020 were studied. Prosthesis components were placed in solid containers in the operating room; in the clinical microbiology laboratory, 400 mL Ringer's solution was added, and containers subjected to vortexing, sonication and then vortexing, followed by centrifugation. Concentrated sonicate fluid was plated on aerobic and anaerobic solid media, and culture results reported semiquantitatively, as no growth, <20, 20–50, 51–100, or >100 CFU/10 mL sonicate fluid. Sonicate cultures from cement spacers and cultures yielding more than 1 microorganism were excluded. Sensitivity and specificity of each cutoff point was evaluated. Results A total of 1448 sonicate fluid cultures were evaluated, 68% from knees and 32% from hips. PJI was present in 644 (44%) cases. Sensitivity of sonicate culture was 75.0% at <20 CFU/10 mL, 55.3% at ≥20 CFU/10 mL, 46.9% at >51 CFU/10 mL, and 39.8% at >100 CFU/10 mL. Specificity was 78.2%, 99.8%, 100%, and 100%, at the 4 cutoff points, respectively. Conclusions A cutoff point for sonicate fluid culture positivity of ≥20 CFU/10 mL is suitable for PJI diagnosis.
Mesothelioma: Pleural, Version 1.2024
Stevenson, James, Ettinger, David S. , Wood, Douglas E. , Aisner, Dara L. , Akerley, Wallace , Bauman, Jessica R. , Bruno, Débora S. , DeCamp, Malcolm M., Desai, Aakash , Dilling, Thomas J. , Dowell, Jonathan E. , Durm, Gregory A. , Garassino, Marina Chiara , Gettinger, Scott , Gubens, Matthew A. , Lackner, Rudy P., Maldonado, Fabien , Morgensztern, Daniel , Mullikin, Trey C. , Ng, Thomas, Otterson, Gregory A. , Owen, Dawn , Patel, Sandip Pravin , Riely, Gregory J. , Riess, Jonathan W. , Shapiro, Theresa A. , Singh, Aditi P. , Tam, Alda L. , Yang, Stephen C. , Yau, Edwin , Gregory, Kristina M., Hang, Lisa, Desai, Aakash P , Bharat, Ankit , Chang, Joe Y. , Chirieac, Lucian R. , Grotz, Travis E. , Lanuti, Michael D. , Lin, Jules , Loo, Billy W. , Lovly, Christine Marie , Massarelli, Erminia , Patil, Tejas , Polanco, Patricio Marcelo , Tanvetyanon, Tawee , Yanagawa, Jane

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 18, 2024 | Volume: 22 | Issue: 2 | Pages: 72-81

10.6004/jnccn.2024.0014 | PMID 38503043 Get It

Mesothelioma is a rare cancer that originates from the mesothelial surfaces of the pleura and other sites, and is estimated to occur in approximately 3,500 people in the United States annually. Pleural mesothelioma is the most common type and represents approximately 85% of these cases. The NCCN Guidelines for Mesothelioma: Pleural provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with pleural mesothelioma. These NCCN Guidelines Insights highlight significant updates to the NCCN Guidelines for Mesothelioma: Pleural, including revised guidance on disease classification and systemic therapy options.
Associations of Circulating Vascular Cell Adhesion Molecule‐1 and Intercellular Adhesion Molecule‐1 With Long‐Term Cardiac Function
Mathew, Daniel T., Peigh, Graham , Larson, Nicholas B. , Allison, Matthew , Shah, Sanjiv J. , Bielinski, Suzette , Larson, Nicholas B , Allison, Matthew A , Shah, Sanjiv J , Patel, Ravi B , Lima, João A.C. , Bielinski, Suzette J. , Patel, Ravi B.

Mayo Clinic

Journal of the American Heart Association | March 18, 2024 | Volume: 13 | Issue: 6 | Pages: No page available

10.1161/jaha.123.032213 | PMID 38497480 Get It

Background Although VCAM‐1 (vascular cell adhesion molecule‐1) and ICAM‐1 (intercellular adhesion molecule‐1) have been associated with incident heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF), the associations of VCAM‐1 and ICAM‐1 with sensitive measures of cardiac structure/function are unclear. The objective of this study is to evaluate associations between VCAM‐1, ICAM‐1, and measures of cardiac structure and function as potential pathways through which cellular adhesion molecules promote HFpEF and AF risk. Methods and Results In MESA (Multi‐Ethnic Study of Atherosclerosis), we evaluated the associations of circulating VCAM‐1 and ICAM‐1 at examination 2 (2002–2004) with measures of cardiac structure/function on cardiac magnetic resonance imaging at examination 5 (2010–2011) after multivariable adjustment. Mediation analysis of left atrial (LA) strain on the association between VCAM‐1 or ICAM‐1 and AF or HFpEF was also performed. Overall, 2304 individuals (63±10 years; 47% men) with VCAM‐1 or ICAM‐1, cardiac magnetic resonance imaging, and covariate data were included in analysis. Higher VCAM‐1 and ICAM‐1 were associated with lower LA peak longitudinal strain and worse global circumferential left ventricular strain but were not associated with left ventricular myocardial scar or interstitial fibrosis. Lower LA peak longitudinal strain mediated 8% (95% CI, 2–30) of the relationship between VCAM‐1 and HFpEF and 9% (95% CI, 2–21) of the relationship between VCAM‐1 and AF. Conclusions Higher VCAM‐1 and ICAM‐1 were associated with lower LA function and left ventricular systolic function but were not associated with myocardial scar or interstitial fibrosis. VCAM‐1 and ICAM‐1 may promote HFpEF and AF risk through impaired LA reservoir function.
How We Treat Primary Hyperoxaluria Type 1
Breeggemann, Matthew C. , Harris, Peter C. , Lieske, John C. , Tasian, Gregory E. , Wood, Kyle D. , Harris, Peter C , Lieske, John C , Tasian, Greg

Mayo Clinic

Clinical Journal of the American Society of Nephrology | March 18, 2024 | Volume: 19 | Issue: 6 | Pages: 800-802

10.2215/cjn.0000000000000460 | PMID 38494457 Get It

Empirical antimicrobial prescribing for pyelonephritis in patients discharged from 15 US Emergency Departments: an opportunity for improvement
Rech, Megan A. , Faine, Brett , Gross, Alan E. , Vakkalanka, J. Priyanka , Brown, Caitlin S. , Harding, Stephanie J. , Slocum, Giles W. , Zimmerman, David E. , Zepeski, Anne , Rewitzer, Stacey , Howington, Gavin T. , Campbell, Matthew J. , Dawson, Jordan, Treu, Cierra N. , Nelson, Lucas , Jones, Mandy , Flack, Tara , Porter, Blake , Sarangarm, Preeyaporn , Mattson, Alicia E , Bailey, Abby M. , Kelly, Gregory , Talan, David A. , Vakkalanka, Priyanka , Campbell, Matt , Rech, Megan A , Faine, Brett A , Gross, Alan , Jones, Mandy

Mayo Clinic

Journal of Antimicrobial Chemotherapy | March 14, 2024 | Volume: 79 | Issue: 5 | Pages: 1038-1044

10.1093/jac/dkae070 | PMID 38482607 Get It

Abstract Background Urinary tract infections (UTIs) are commonly treated in the emergency department (ED), and unfortunately, resistance to first-line agents is increasing. Objectives To characterize treatment of pyelonephritis in a nationally representative sample of ED patients and to identify patient- and treatment-specific factors associated with receiving initial inactive antibiotics. Methods We conducted a multicentre, observational cohort study utilizing the Emergency Medicine PHARMacotherapy Research NETwork (EMPHARM-NET), comprising 15 geographically diverse US EDs. All patients ≥18 years of age with a diagnosis of pyelonephritis between 2018 and 2020 were included. The primary endpoint was the proportion of patients who received initial inactive empirical antibiotic therapy and to identify predictive factors of inactive antibiotic therapy. Results Of the 3714 patients evaluated, 223 had culture-positive pyelonephritis. Median patient age was 50.1 years and patients were mostly female (78.3%). Overall, 40.4% of patients received an IV antibiotic, most commonly ceftriaxone (86.7%). The most frequently prescribed antibiotics were cefalexin (31.8%), ciprofloxacin (14.3%), cefdinir (13.5%) and trimethoprim/sulfamethoxazole (12.6%). Overall, 10.3% of patients received initial inactive therapy. After adjustment in a multivariable analysis, long-acting IV antibiotic was predictive of inactive therapy (OR 0.23, 95% CI 0.07–0.83). Conclusions In our prospective, multicentre observational study, we found that only 40.4% of patients with pyelonephritis received empirical IV antibiotics in the ED, contributing to inactive therapy. Receipt of long-acting IV antibiotics was independently associated with a decreased rate of initial inactive therapy. This reinforces guideline recommendations to administer long-acting IV antibiotics empirically in the ED upon suspicion of pyelonephritis.
Medical Maintenance Therapy Following Laser Excision in Patients With Granulomatosis With Polyangiitis (GPA)‐Associated Subglottic Stenosis
Aden, Aisha A. , Awadallah, Andrew S. , Xie, Katherine , Wallerius, Katherine P. , O’Byrne, Thomas J., Bowen, Andrew J. , Edell, Eric S. , Bayan, Semirra L. , Ekbom, Dale C. , Xie, Katherine Z , Bowen, Andrew Jay , Awadallah, Andrew , Bayan, Semirra , Koster, Matthew J.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | March 14, 2024 | Volume: 171 | Issue: 1 | Pages: 180-187

10.1002/ohn.694 | PMID 38482973 Get It

AbstractObjectiveTo report on a series of patients with cANCA/PR3‐positive, granulomatosis with polyangiitis (GPA)‐associated subglottic stenosis (SGS) and evaluate response to medical maintenance therapy with rituximab versus other immunosuppressants following initial endoscopic laser excision.Study DesignRetrospective chart review.SettingTertiary academic center.MethodsA retrospective chart review of patients with SGS and cANCA/PR3‐positive GPA who received immunosuppressive maintenance therapy following endoscopic laser excision at our institution from June 1989 to March 2020 was performed. Data pertaining to patient demographics, clinical features, medications, and endoscopic laser procedures were collected.ResultsA total of 27 patients (15 women) with mean age (range) of 40 (19‐59) years and mean (range) follow‐up of 12.6 years (1.5‐28.6) were identified. Sixteen patients (60%) had limited GPA. Six patients (24%) had previously received local intervention with open surgery (n = 1, 4%) or endoscopic techniques (n = 5, 20%). All patients experienced symptom improvement following initial CO2 laser excision at our institution without any procedural complications or adverse events. Following initial laser excision, 15 patients (60%) were treated with rituximab and 10 patients (40%) were treated with nonrituximab immunosuppressive agents. Patients treated with rituximab were less likely to recur (P = 0.040). Limited GPA was associated with an increased incidence of recurrence (P = 0.031). Median time (years) to recurrence (range) was 3.2 (0.3‐19.3) and was not significantly associated with treatment or GPA subtype.ConclusionEndoscopic CO2 laser excision is a safe and effective local intervention for GPA‐associated SGS. Medical maintenance therapy with rituximab reduces risk of recurrence following initial laser excision relative to treatment with non‐rituximab agents.
Does climate impact inflatable penile prosthesis infection (IPP) risk? Assessment of temperature and dew point on IPP infections
Barham, David W. , Pyrgidis, Nikolaos , Amini, Eliad, Hammad, Muhammed , Andrianne, Robert, Gross, Kelli, Hatzichristodoulou, Georgios , Hotaling, James M. , Hsieh, Tung‐Chin , Lentz, Aaron , Modgil, Vaibhav , Osmonov, Daniar , Park, Sung Hun , Pearce, Ian , Perito, Paul , Sadeghi‐Nejad, Hossein , Sempels, Maxime, Suarez‐Sarmiento, Alfredo, Simhan, Jay , Warner, J, Ziegelmann, Matthew , Yafi, Faysal A. , Gross, Martin , collaborators, on behalf of the PUMP (Prosthetic Urology Multi-institutional Partnership), Jones, James M , Hammad, Muhammed A M , Miller, Jake A. , Burnett, Arthur L. “Bud” , Jenkins, Lawrence C. , Jones, James M. , Renterghem, Koenraad van , collaborators, on behalf of the PUMP (Prosthetic Urology Multi-institutional Partnership)

Mayo Clinic

The Journal of Sexual Medicine | March 14, 2024 | Volume: 21 | Issue: 5 | Pages: 500-504

10.1093/jsxmed/qdae023 | PMID 38481017 Get It

Abstract Background Variations in climate have been associated with a greater risk of surgical site infections, urinary tract infections, and changes in the skin microbiome; however, limited data exist on the impact of climate on inflatable penile prosthesis (IPP) infections. Aim We sought to evaluate the impact of climate on the risk of IPP infections in a large international, multicenter cohort. Methods We performed a multi-institutional, retrospective study of patients undergoing IPP surgery. We then evaluated whether the month or season, during which surgery was performed, affected device infections. Implant infections were defined as infections requiring device explantation. A univariate logistic regression analysis was undertaken. Outcomes Our primary outcome was implant infection. Results A total of 5289 patients with a mean age of 62.2 ± 10.8 years received IPP placement. There was a fairly even distribution of implants performed in each season. A total of 103 (1.9%) infections were recorded. There were 32 (31.1%) IPP infections in patients who underwent surgery in the summer, followed by 28 (27.2%) in the winter, 26 (25.2%) in the spring, and 17 (16.5%) in the fall. No statistically significant differences were recorded in terms of season (P = .19) and month (P = .29). The mean daily temperature (P = .43), dew point (P = .43), and humidity (P = .92) at the time of IPP placement was not associated with infection. Clinical Implications These findings provide reassurance to prosthetic urologists that infection reduction strategies do not need to be tailored to local climate. Strengths and Limitations Climate data were not directly recorded for each hospital, but rather based on the monthly averages in the city where the surgery was performed. Conclusion The climate at time of IPP placement and time of year of surgery is not associated with IPP infection risk.